
Inbiomotion
Developer of biomarkers designed to predict bone metastasis and improve the quality of life for breast cancer patients. The company's bio-markers are focused on the development of a diagnostic assay b...
Valuation
$0
Share Price
N/A
Total Raised
$13.2M
Last Round
N/A